Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Annals of the American Thoracic Society
|
May 10, 2022
Physical Activity, Exercise Capacity, and Body Composition in U.S. Veterans with Chronic Obstructive Pulmonary Disease
Emily S Wan, Madeline Polak, Rebekah L Goldstein, et al.
Scientific Reports
|
February 5, 2022
Performance of bioelectrical impedance analysis compared to dual X-ray absorptiometry (DXA) in Veterans with COPD
Paola N Cruz Rivera, Rebekah L Goldstein, Madeline Polak, et al.
Respiratory Medicine
|
February 15, 2020
Long-term effects of web-based pedometer-mediated intervention on COPD exacerbations
Emily S Wan, Ana Kantorowski, Madeline Polak, et al.
ERJ Open Research
|
September 3, 2021
A randomised trial of a web-based physical activity self-management intervention in COPD
Stephanie A Robinson, J Allen Cooper, Rebekah L Goldstein, et al.
Gynecologic Oncology Reports
|
March 1, 2024
Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer
Panagiotis A Konstantinopoulos, Niya Xiong, Carolyn Krasner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2022
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer
Felipe Batalini, Niya Xiong, Nabihah Tayob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers
Felipe Batalini, Doga C Gulhan, Victor Mao, et al.
Nature Communications
|
March 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial
Rebecca L Porter, Yinglu Zhou, Nebiyat Eskndir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2022
A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer
Panagiotis A Konstantinopoulos, Elizabeth K Lee, Niya Xiong, et al.
Gynecologic Oncology Reports
|
April 18, 2022
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
Elizabeth H Stover, Niya Xiong, Andrea P Myers, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Annals of the American Thoracic Society
|
May 10, 2022
Physical Activity, Exercise Capacity, and Body Composition in U.S. Veterans with Chronic Obstructive Pulmonary Disease
Emily S Wan, Madeline Polak, Rebekah L Goldstein, et al.
Scientific Reports
|
February 5, 2022
Performance of bioelectrical impedance analysis compared to dual X-ray absorptiometry (DXA) in Veterans with COPD
Paola N Cruz Rivera, Rebekah L Goldstein, Madeline Polak, et al.
Respiratory Medicine
|
February 15, 2020
Long-term effects of web-based pedometer-mediated intervention on COPD exacerbations
Emily S Wan, Ana Kantorowski, Madeline Polak, et al.
ERJ Open Research
|
September 3, 2021
A randomised trial of a web-based physical activity self-management intervention in COPD
Stephanie A Robinson, J Allen Cooper, Rebekah L Goldstein, et al.
Gynecologic Oncology Reports
|
March 1, 2024
Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer
Panagiotis A Konstantinopoulos, Niya Xiong, Carolyn Krasner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 12, 2022
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer
Felipe Batalini, Niya Xiong, Nabihah Tayob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers
Felipe Batalini, Doga C Gulhan, Victor Mao, et al.
Nature Communications
|
March 27, 2026
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial
Rebecca L Porter, Yinglu Zhou, Nebiyat Eskndir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 29, 2022
A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer
Panagiotis A Konstantinopoulos, Elizabeth K Lee, Niya Xiong, et al.
Gynecologic Oncology Reports
|
April 18, 2022
A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma
Elizabeth H Stover, Niya Xiong, Andrea P Myers, et al.
Page
of 2